Gleb Kuznetsov is co-founder and CEO of Manifold Bio, a biotechnology company aiming to revolutionize protein therapeutics discovery through novel measurement and design technologies. Gleb comes from an interdisciplinary technical background spanning computational and molecular biology. He completed a Ph.D. in the Harvard Biophysics program combining massively parallel capabilities of DNA sequencing, DNA synthesis, and machine learning technologies.

‍